Cargando…
Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global crisis. Clinical candidates with high efficacy, ready availability, and that do not develop resistance are in urgent need. Despite that screening to repurpose clinicall...
Autores principales: | Peng, Haoran, Ding, Cuiling, Jiang, Liangliang, Tang, Wanda, Liu, Yan, Zhao, Lanjuan, Yi, Zhigang, Ren, Hao, Li, Chong, He, Yanhua, Zheng, Xu, Tang, Hailin, Chen, Zhihui, Qi, Zhongtian, Zhao, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science China Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713546/ https://www.ncbi.nlm.nih.gov/pubmed/34962614 http://dx.doi.org/10.1007/s11427-021-2031-7 |
Ejemplares similares
-
High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses
por: Ding, Cuiling, et al.
Publicado: (2022) -
Zika Virus Induces Autophagy in Human Umbilical Vein Endothelial Cells
por: Peng, Haoran, et al.
Publicado: (2018) -
An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery
por: Willoughby, Lee F., et al.
Publicado: (2013) -
Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo
por: Qian, Xijing, et al.
Publicado: (2022) -
Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening
por: Scarpino, Andrea, et al.
Publicado: (2019)